Vanguard Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.26B Buy
37,717,944
+101,992
+0.3% +$9.06M 0.07% 230
2026
Q2
$3.4B Sell
37,615,952
-111,840
-0.3% -$9.37M 0.07% 234
2026
Q1
$3.02B Hold
37,727,792
– – 0.07% 227

Other funds holding EW

Vanguard Capital Management's EW Position: Q3 2026 in Review

Vanguard Capital Management increased its Edwards Lifesciences (EW) stake by 0.27% in Q3 2026, buying an estimated $9.06M and bringing the position to 37,717,944 shares worth $3.26B. The position accounts for 0.07% of the portfolio, ranked #230.

Vanguard Capital Management first reported a position in EW in Q1 2026 and has held it in 3 quarters since. The position peaked at $3.4B in Q2 2026. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Vanguard Capital Management held 37,717,944 shares of Edwards Lifesciences worth $3.26B as of Q3 2026.
  • Vanguard Capital Management bought 101,992 Edwards Lifesciences shares in Q3 2026, an estimated $9.06M.
  • Edwards Lifesciences made up 0.07% of Vanguard Capital Management's portfolio in Q3 2026, its #230 holding.
  • Vanguard Capital Management first reported a position in Edwards Lifesciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Edwards Lifesciences position peaked at $3.4B in Q2 2026.
  • 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.